Tourniquet Use and Anesthesiology Considerations in Patients With Hypermobile Ehlers-Danlos Syndrome: Balancing Orthopedic Needs With Anesthetic Safety
Abstract
Hypermobile Ehlers-Danlos syndrome (hEDS) is a hereditary connective tissue disorder characterized by generalized joint hypermobility, soft tissue fragility, chronic pain, and autonomic dysfunction. Although major vascular complications are uncommon in hEDS, affected individuals frequently undergo orthopedic procedures, including ligament reconstructions, tendon repair, and joint stabilization, due to recurrent dislocations and musculoskeletal injury. Consequently, careful evaluation of pneumatic tourniquet use in this patient population is warranted. Pneumatic tourniquets are widely used in extremity orthopedic surgery to reduce blood loss and improve visualization. However, their effects on peripheral nerve integrity, pain outcomes, and soft tissue injury in patients with hEDS remain poorly understood. These concerns are particularly relevant in the context of regional anesthesia, where chronic pain syndromes and autonomic dysfunction may complicate perioperative analgesia and postoperative neurologic assessments. This narrative review examines the pathophysiology of hEDS and explores anesthetic and orthopedic considerations related to tourniquet use in this patient population. While tourniquets offer clear intraoperative advantages, patients with hEDS may be at increased risk for skin injury, compression neuropraxia, exaggerated ischemia-reperfusion pain, and delayed postoperative recovery. In the absence of evidence-based guidelines, tourniquet use in patients with hEDS…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.